Symbols / MGRX
MGRX Chart
About
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Health Information Servi | Market Cap | 8.53M |
| Enterprise Value | 6.91M | Income | -20.77M | Sales | 466.91K |
| Book/sh | 1.13 | Cash/sh | 0.04 | Dividend Yield | — |
| Payout | 0.00% | Employees | 3 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 18.26 | P/B | 0.46 | P/C | — |
| EV/EBITDA | -0.42 | EV/Sales | 14.80 | Quick Ratio | 0.60 |
| Current Ratio | 0.74 | Debt/Eq | 0.71 | LT Debt/Eq | — |
| EPS (ttm) | -2.72 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -36.80% | Earnings | — | ROA | -73.78% |
| ROE | -136.16% | ROIC | — | Gross Margin | 60.62% |
| Oper. Margin | -89.14% | Profit Margin | 0.00% | Shs Outstand | 16.29M |
| Shs Float | 9.14M | Short Float | 2.22% | Short Ratio | 0.73 |
| Short Interest | — | 52W High | 5.33 | 52W Low | 0.34 |
| Beta | 2.71 | Avg Volume | 6.54M | Volume | 3.51M |
| Target Price | — | Recom | None | Prev Close | $0.55 |
| Price | $0.52 | Change | -3.94% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.52
Latest analyst target
3. DCF / Fair value
$0.76
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.52
Low
—
High
—
Mean
—
- Here’s Why Mangoceuticals Stock (MGRX) Rocketed Today - TipRanks Fri, 20 Feb 2026 14
- $MGRX stock is up 74% today. Here's what we see in our data. - Quiver Quantitative Fri, 20 Feb 2026 14
- MGRX (Mangoceuticals, Inc., NASDAQ) up 50.75% intraday 20 Feb 2026: TRT sales drive heavy volume - Meyka Fri, 20 Feb 2026 18
- $99 testosterone injections give MangoRx a 336% sales surge - Stock Titan hu, 19 Feb 2026 21
- Mangoceuticals stock slips before the bell after a 49% surge — what traders watch next for MGRX - TechStock² Mon, 23 Feb 2026 10
- 2/20/2026 Market Update - Winners: ADVB, MGRX, CETY - Losers: ROC, VEEE, GRAL - S&P 500: 0.7% - Trefis Sat, 21 Feb 2026 05
- Mangoceuticals stock surges on TRT program growth By Investing.com - Investing.com Nigeria Fri, 20 Feb 2026 14
- Mangoceuticals Stock Surges On Early Success Of Subscription TRT Model - Bitget hu, 19 Feb 2026 23
- Mangoceuticals down after denying Lilly, Novo deals (MGRX) - Seeking Alpha Fri, 14 Nov 2025 08
- Mangoceuticals stock skyrockets 50% Friday: What's driving the rally? - MSN ue, 24 Feb 2026 11
- Telehealth wellness brand MangoRx pulls in $2.5M from investors - Stock Titan hu, 18 Dec 2025 08
- CFO Johnston sells Mangoceuticals (MGRX) shares for $11,279 - Investing.com ue, 09 Dec 2025 08
- Mangoceuticals Highlights Promising MGX-0024 Poultry Antiviral Data - TipRanks Mon, 23 Feb 2026 21
- Insider Sale: CFO of $MGRX Sells 10,000 Shares - Quiver Quantitative ue, 09 Dec 2025 08
- Mangoceuticals stock surges on TRT program growth - Investing.com South Africa Fri, 20 Feb 2026 14
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 3333 | 3884.0 | — | Sale at price 1.17 per share. | JOHNSTON EUGENE M | Chief Financial Officer | — | 2025-12-15 00:00:00 | D |
| 1 | 5000 | 5975.0 | — | Sale at price 1.20 per share. | JOHNSTON EUGENE M | Chief Financial Officer | — | 2025-12-09 00:00:00 | D |
| 2 | 10000 | 11280.0 | — | Sale at price 1.13 per share. | JOHNSTON EUGENE M | Chief Financial Officer | — | 2025-12-05 00:00:00 | D |
| 3 | 125000 | 152875.0 | — | Sale at price 1.22 per share. | HAMILTON ALEX P | Director | — | 2025-11-19 00:00:00 | D |
| 4 | 100000 | — | — | Stock Award(Grant) at price 0.00 per share. | JOHNSTON EUGENE M | Chief Financial Officer | — | 2025-09-09 00:00:00 | D |
| 5 | 100000 | — | — | Stock Award(Grant) at price 0.00 per share. | MYERS KENNY | Director | — | 2025-09-09 00:00:00 | D |
| 6 | 100000 | — | — | Stock Award(Grant) at price 0.00 per share. | D'ALESSIO LORRAINE PAMELA | Director | — | 2025-09-09 00:00:00 | D |
| 7 | 100000 | — | — | Stock Award(Grant) at price 0.00 per share. | HAMILTON ALEX P | Director | — | 2025-09-09 00:00:00 | D |
| 8 | 25000 | — | — | Stock Award(Grant) at price 0.00 per share. | JOHNSTON EUGENE M | Chief Financial Officer | — | 2024-11-11 00:00:00 | D |
| 9 | 800000 | nan | — | — | COHEN JACOB D. | Chief Executive Officer | — | 2024-08-26 00:00:00 | I |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -7.90M | -9.13M | -1.99M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -8.71M | -9.21M | -2.00M |
| ReconciledDepreciation | 791.24K | 79.87K | 3.86K |
| ReconciledCostOfRevenue | 166.20K | 220.12K | 4.09K |
| EBITDA | -7.90M | -9.13M | -1.99M |
| EBIT | -8.69M | -9.21M | -1.99M |
| NetInterestIncome | -13.70K | 0.00 | -6.47K |
| InterestExpense | 13.70K | 0.00 | 6.47K |
| NormalizedIncome | -8.71M | -9.21M | -2.00M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -8.71M | -9.21M | -2.00M |
| TotalExpenses | 9.31M | 9.95M | 2.00M |
| TotalOperatingIncomeAsReported | -7.97M | -9.22M | -1.99M |
| DilutedAverageShares | 1.98M | 1.07M | 1.02M |
| BasicAverageShares | 1.98M | 1.07M | 1.02M |
| DilutedEPS | -4.84 | -8.58 | -1.96 |
| BasicEPS | -4.84 | -8.58 | -1.96 |
| DilutedNIAvailtoComStockholders | -8.71M | -9.21M | -2.00M |
| NetIncomeCommonStockholders | -8.71M | -9.21M | -2.00M |
| NetIncome | -8.71M | -9.21M | -2.00M |
| MinorityInterests | 1.08K | 0.00 | |
| NetIncomeIncludingNoncontrollingInterests | -8.71M | -9.21M | -2.00M |
| NetIncomeContinuousOperations | -8.71M | -9.21M | -2.00M |
| TaxProvision | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -8.71M | -9.21M | -2.00M |
| OtherIncomeExpense | 6.47K | ||
| OtherNonOperatingIncomeExpenses | 6.47K | ||
| NetNonOperatingInterestIncomeExpense | -13.70K | 0.00 | -6.47K |
| InterestExpenseNonOperating | 13.70K | 0.00 | 6.47K |
| OperatingIncome | -8.69M | -9.22M | -1.99M |
| OperatingExpense | 9.07M | 9.65M | 2.00M |
| OtherOperatingExpenses | 453.75K | 1.10M | |
| DepreciationAmortizationDepletionIncomeStatement | 721.53K | 0.00 | |
| DepreciationAndAmortizationInIncomeStatement | 721.53K | 0.00 | |
| Amortization | 721.53K | 0.00 | |
| AmortizationOfIntangiblesIncomeStatement | 721.53K | 0.00 | |
| SellingGeneralAndAdministration | 7.90M | 8.55M | 2.00M |
| SellingAndMarketingExpense | 1.48M | 2.10M | 352.86K |
| GeneralAndAdministrativeExpense | 6.42M | 6.45M | 1.64M |
| OtherGandA | 3.00M | 3.32M | 1.64M |
| SalariesAndWages | 3.42M | 3.13M | 0.00 |
| GrossProfit | 379.96K | 431.50K | 4.85K |
| CostOfRevenue | 235.91K | 299.99K | 4.09K |
| TotalRevenue | 615.87K | 731.49K | 8.94K |
| OperatingRevenue | 615.87K | 731.49K | 8.94K |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 3.25M | 1.43M | 1.02M | 1.02M |
| ShareIssued | 3.25M | 1.43M | 1.02M | 1.02M |
| NetDebt | 91.35K | 16.72K | ||
| TotalDebt | 214.96K | 128.68K | 352.87K | 39.27K |
| TangibleBookValue | -1.29M | 774.75K | 614.03K | -16.72K |
| InvestedCapital | 14.10M | 774.75K | 781.49K | 22.55K |
| WorkingCapital | -1.35M | 624.32K | 434.03K | -16.72K |
| NetTangibleAssets | -1.29M | 774.75K | 614.03K | -16.72K |
| CapitalLeaseObligations | 64.96K | 128.68K | 185.41K | 0.00 |
| CommonStockEquity | 13.95M | 774.75K | 614.03K | -16.72K |
| PreferredStockEquity | 98.00 | |||
| TotalCapitalization | 13.95M | 774.75K | 614.03K | -16.72K |
| TotalEquityGrossMinorityInterest | 13.95M | 774.75K | 614.03K | -16.72K |
| MinorityInterest | -1.08K | 0.00 | ||
| StockholdersEquity | 13.95M | 774.75K | 614.03K | -16.72K |
| OtherEquityInterest | -825.71K | |||
| GainsLossesNotAffectingRetainedEarnings | -9.85K | 0.00 | ||
| OtherEquityAdjustments | -9.85K | |||
| RetainedEarnings | -20.81M | -11.23M | -2.02M | -17.70K |
| AdditionalPaidInCapital | 35.59M | 12.00M | 2.63M | 181.00 |
| CapitalStock | 423.00 | 148.00 | 1.34K | 800.00 |
| CommonStock | 325.00 | 148.00 | 1.34K | 800.00 |
| PreferredStock | 98.00 | 0.00 | ||
| TotalLiabilitiesNetMinorityInterest | 1.43M | 276.04K | 389.26K | 39.27K |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 0.00 | 64.96K | 128.68K | 0.00 |
| LongTermDebtAndCapitalLeaseObligation | 0.00 | 64.96K | 128.68K | 0.00 |
| LongTermCapitalLeaseObligation | 0.00 | 64.96K | 128.68K | 0.00 |
| CurrentLiabilities | 1.43M | 211.08K | 260.58K | 39.27K |
| CurrentDebtAndCapitalLeaseObligation | 214.96K | 63.72K | 224.19K | 39.27K |
| CurrentCapitalLeaseObligation | 64.96K | 63.72K | 56.73K | 0.00 |
| CurrentDebt | 150.00K | 167.46K | 39.27K | |
| CurrentNotesPayable | 150.00K | 0.00 | 167.46K | 39.27K |
| PayablesAndAccruedExpenses | 1.21M | 147.36K | 36.39K | 0.00 |
| Payables | 1.21M | 147.36K | 36.39K | |
| OtherPayable | 373.00K | |||
| TotalTaxPayable | 0.00 | 6.59K | 2.72K | 0.00 |
| AccountsPayable | 837.50K | 140.76K | 33.67K | |
| TotalAssets | 15.37M | 1.05M | 1.00M | 22.55K |
| TotalNonCurrentAssets | 15.29M | 215.39K | 308.68K | 0.00 |
| NonCurrentPrepaidAssets | 16.94K | 16.94K | 0.00 | |
| GoodwillAndOtherIntangibleAssets | 15.23M | 0.00 | ||
| OtherIntangibleAssets | 15.23M | |||
| NetPPE | 62.30K | 215.39K | 291.74K | 0.00 |
| AccumulatedDepreciation | -2.26K | -28.75K | -3.86K | 0.00 |
| GrossPPE | 64.56K | 244.14K | 295.60K | 0.00 |
| OtherProperties | 59.49K | 239.08K | 290.54K | |
| MachineryFurnitureEquipment | 5.06K | 5.06K | 5.06K | 0.00 |
| CurrentAssets | 75.59K | 835.40K | 694.61K | 22.55K |
| PrepaidAssets | 16.94K | 77.89K | 11.74K | 0.00 |
| Inventory | 0.00 | 18.50K | 0.00 | |
| FinishedGoods | 0.00 | 18.50K | ||
| CashCashEquivalentsAndShortTermInvestments | 58.65K | 739.01K | 682.86K | 22.55K |
| CashAndCashEquivalents | 58.65K | 739.01K | 682.86K | 22.55K |
| CashFinancial | 58.65K | 739.01K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| FreeCashFlow | -4.86M | -7.00M | -1.39M |
| RepaymentOfDebt | 0.00 | -167.46K | -25.07K |
| IssuanceOfDebt | 150.00K | 0.00 | 75.00K |
| IssuanceOfCapitalStock | 3.98M | 6.20M | 2.00M |
| CapitalExpenditure | -3.52K | -43.10K | |
| InterestPaidSupplementalData | 0.00 | 0.00 | 0.00 |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 0.00 |
| EndCashPosition | 58.65K | 739.01K | 682.86K |
| BeginningCashPosition | 739.01K | 682.86K | 22.55K |
| EffectOfExchangeRateChanges | -9.85K | 0.00 | |
| ChangesInCash | -670.51K | 56.15K | 660.31K |
| FinancingCashFlow | 4.13M | 7.06M | 2.05M |
| CashFlowFromContinuingFinancingActivities | 4.13M | 7.06M | 2.05M |
| ProceedsFromStockOptionExercised | 0.00 | 1.02M | 0.00 |
| NetPreferredStockIssuance | 2.65M | 0.00 | |
| PreferredStockIssuance | 2.65M | 0.00 | |
| NetCommonStockIssuance | 1.33M | 6.20M | 2.00M |
| CommonStockIssuance | 1.33M | 6.20M | 2.00M |
| NetIssuancePaymentsOfDebt | 150.00K | -167.46K | 49.93K |
| NetShortTermDebtIssuance | 150.00K | -167.46K | 49.93K |
| ShortTermDebtPayments | 0.00 | -167.46K | -25.07K |
| ShortTermDebtIssuance | 150.00K | 0.00 | 75.00K |
| InvestingCashFlow | 65.00K | -3.52K | -43.10K |
| CashFlowFromContinuingInvestingActivities | 65.00K | -3.52K | -43.10K |
| NetOtherInvestingChanges | 65.00K | ||
| NetPPEPurchaseAndSale | 0.00 | -3.52K | -43.10K |
| PurchaseOfPPE | 0.00 | -3.52K | -43.10K |
| OperatingCashFlow | -4.86M | -7.00M | -1.35M |
| CashFlowFromContinuingOperatingActivities | -4.86M | -7.00M | -1.35M |
| ChangeInWorkingCapital | 660.38K | -13.47K | 18.87K |
| ChangeInOtherCurrentLiabilities | -90.72K | -56.73K | 185.41K |
| ChangeInPayablesAndAccruedExpense | 690.14K | 110.97K | 36.39K |
| ChangeInPayable | 690.14K | 110.97K | 36.39K |
| ChangeInAccountPayable | 696.74K | 107.09K | 33.67K |
| ChangeInTaxPayable | -6.59K | 3.88K | 2.72K |
| ChangeInIncomeTaxPayable | -6.59K | 3.88K | 2.72K |
| ChangeInPrepaidAssets | 60.95K | -49.21K | -28.69K |
| ChangeInInventory | 0.00 | -18.50K | 0.00 |
| ChangeInReceivables | 54.98K | -174.24K | |
| OtherNonCashItems | 2.11M | 1.52M | 546.54K |
| StockBasedCompensation | 248.68K | 624.46K | 234.09K |
| AssetImpairmentCharge | 18.50K | 0.00 | |
| DepreciationAmortizationDepletion | 791.24K | 79.87K | 3.86K |
| DepreciationAndAmortization | 791.24K | 79.87K | 3.86K |
| AmortizationCashFlow | 781.30K | 54.98K | |
| AmortizationOfIntangibles | 781.30K | 54.98K | |
| Depreciation | 9.94K | 24.89K | 3.86K |
| OperatingGainsLosses | 18.39K | -151.82K | |
| GainLossOnInvestmentSecurities | -151.82K | ||
| NetIncomeFromContinuingOperations | -8.71M | -9.21M | -2.00M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for MGRX
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|